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Gene silencing: Two faces of SIR2
Daniel E. Gottschling
There are still many mysteries surrounding how
silenced regions of the eukaryotic genome are
created and maintained. But recent discoveries about
the most evolutionarily conserved silencing protein,
Sir2p, have provided new mechanistic insights into
these processes.
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The great Drosophila geneticist, H.J. Muller, defined an
‘ever-sporting’ phenotype upon observing flies that had
mosaic patterns of color in their eyes [1]. The phenotype
arose after chromosome rearrangements were induced by
X-ray irradiation that caused an eye color gene to be
moved into centromeric heterochromatin. These experi-
ments heralded the beginning of a genetic analysis of
chromosome structure and its role in gene regulation. This
phenomenon, later called position effect variegation,
allowed biologists to appreciate that the structure of a par-
ticular region of the genome, as defined by its chromatin,
confers special properties that can prevent gene expres-
sion, inhibit DNA recombination and replication, and
affect chromosome segregation [2].
Specialized domains of chromatin exist throughout genomes
of eukaryotes and are not limited to heterochromatin or
centromeres. They extend to developmentally regulated
regions of the genome, such as the homeotic gene cluster
in Drosophila, to whole chromosomes, such as the inactive
X chromosome in female mammals, or to the nucleolus,
the home of ribosomal RNA synthesis [3–5]. Perhaps one
of the best-defined systems for studying special chromatin
domains has been the budding yeast, Saccharomyces cere-
visiae [6]. HML and HMR, the loci that contain information
specifying yeast mating type, were the first examples of
‘silent’ chromatin. Genes within these loci, while compe-
tent for transcription, are repressed as a result of the
special chromatin structure they are packaged in. 
The DNA in all eukaryotes is packaged as chromatin in
units called nucleosomes, which consist of approximately
146 base pairs of DNA wrapped around an octamer con-
sisting of two copies each of the histone proteins H2A,
H2B, H3 and H4 [7]. The amino termini of each of the
histones are tails that stick out of the nucleosome and are
rich in lysines [8]. These amino-terminal tail lysines serve
as sites of reversible covalent modifications, such as acety-
lation. In yeast silent chromatin, which includes telomeric
regions of the genome as well as the silent mating-type
loci, the amino-terminal tails of histone H3 and H4 are
hypoacetylated relative to the rest of the genome [9].
Interestingly, hypoacetylation of histones H3 and H4 is
also seen in silent chromatin of other organisms, such as in
centromeric heterochromatin and along the inactive
X chromosome in female mammals. These observations
suggest that an understanding of how histones within
silent chromatin become hypoacetylated is critical for
elucidating the mechanisms of silent chromatin formation.
Does hypoacetylation occur in situ, or are a special subset
of hypoacetylated histones deposited specifically to
silenced domains?
While the hypoacetylated histones H3 and H4 are the
foundation for silent chromatin in yeast, other proteins are
required as well [10]. The critical components are the
‘silent information regulator’ (Sir) proteins, Sir2p, Sir3p
and Sir4p. Sir3p appears to blanket the underlying nucleo-
somes by interacting with the hypoacetylated histone H3
and H4 tails, thus impeding access to the DNA by
transcription, replication and recombination machinery.
Sir4p also interacts with the histone tails and may provide
further stabilization of the silent chromatin structure. Sir3p
and Sir4p are recruited to silent loci by interactions with
sequence-specific DNA-binding proteins, such as Rap1.
Until recently, the role of Sir2p has been more enigmatic.
While experiments indicate that Sir2p interacts with Sir3p
and Sir4p in the silent chromatin complex, there was no
compelling evidence that it binds to DNA or histones
directly. Subsequent work from the laboratory of Jim
Broach [11] hinted that Sir2p might be important in creat-
ing hypoacetylated histones. When Sir2p was highly over-
expressed it was toxic to cells, but the histones within
these cells appeared to be somewhat less acetylated than
those in normal cells [11]. While there was no biochemical
evidence that Sir2 was a deacetylase, this result proved to
foreshadow Sir2p’s function.
In addition to its roles in silencing the HM loci and genes
located in telomeric regions of the genome, Sir2p is also
involved in a special chromatin structure at the nucleolus
in yeast, though it does so without the help of its Sir
protein partners. In a complex with Net1p, Sir2p acts to
inhibit recombination within the ribosomal (r)DNA array
and reduce expression of the rDNA genes as well as RNA
polymerase II-transcribed marker genes that are inserted
within the array [12–14]. 
Sir2p is the only Sir protein that is highly conserved [15].
In S. cerevisiae alone, there are four Sir2p homologues
encoded by the HST1–4 genes. Clear Sir2p homologues
occur, not only throughout eukaryotes, but in eubacteria
and archea as well. The significance of the similarity is
unclear, however, as one of the homologues resides in the
cytoplasm, and eubacteria have no histones nor are they
known to have silent chromatin [16]. 
The discoveries
The first break in uncovering a biochemical activity from
Sir2p came from work on one of its prokaryotic homologues,
the Salmonella typhimurium protein CobB [17]. CobB was
found provisionally to substitute for CobT, an enzyme that
catalyzes the transfer of 5′-ribose phosphate from nicotinate
mononucleotide during the biosynthesis of vitamin B12.
Subsequent biochemical studies identified a nicotinamide
adenine dinucleotide (NAD)-dependent ADP-ribosyltrans-
ferase activity associated with CobB and also with a human
Sir2p homologue [18]. Shortly thereafter, a similar weak
activity was reported for S. cerevisiae Sir2p, which was shown
to transfer ADP-ribose from NAD to itself and to histones
in vitro [19]. A point mutation in the conserved Sir2p
domain that eliminated the in vitro ADP-ribose transfer
activity also abolished silencing at loci normally affected
in vivo. The mutant Sir2p could still interact with the other
Sir proteins or Net1p, though its presence at silent loci was
diminished. These observations suggested that Sir2p acts
by ADP-ribosylating proteins, perhaps histones, at silent
loci in order to create silent chromatin. 
Following up on these observations, three papers [20–22]
have been published this year that put a very interesting
twist on the Sir2p enzymatic activity story. In one study
[20], the analysis was based on principals learned, but
often forgotten, in college biochemistry. Landry et al.
[20] hypothesized that, if Sir2p has ADP-ribosyltrans-
ferase activity, then the protein might cleave the glyco-
sidic bond between nicotinamide and ADP-ribose in
NAD. This would create the following equilibrium:
enzyme + NAD ↔ enzyme–ADP-ribose + nicotinamide.
If the hypothesis were true, then incubating radioactive
nicotinamide with Sir2p and unlabeled NAD would result
in the NAD becoming radioactively labeled in an enzyme
concentration- and time-dependent manner. No labeling
of NAD occurred when Sir2p was the only protein in the
mixture, but if histones isolated from chicken erythrocytes
were added, then NAD became labeled.
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Figure 1
The two biochemical reactions carried out by
Sir2 protein and its homologues. (a) Sir2p,
acting as a deacetylase, removes an acetyl
group from N-acetyllysine. (b) Sir2p catalyses
the conversion of NAD+ into nicotinamide and
ADP-ribose. ‘R’ signifies the moiety that
becomes ADP-ribosylated. It is unclear
whether R is normally Sir2p or a different
molecule. These two reactions appear to be
interdependent; the deacetylase activity
requires NAD+, and the bond cleavage of
NAD+ is stimulated by acetyllysine.
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Closer inspection of the histone requirement in the NAD
exchange reaction revealed that the acetylated lysines in
the amino-terminal tails were needed. In fact, replace-
ment of acetylated histones with purified acetyl–lysine
was sufficient to trigger the NAD exchange reaction. The
NAD exchange reaction occurred at low levels of enzyme,
but in contrast to the earlier studies, no transfer of ADP-
ribose to histones was detected. When Landry et al. [20]
turned their attention to the fate of the acetylated histones
in these reactions, they made the exciting discovery that
acetyl groups were removed from the lysines by Sir2p, or
any of its homologues. Thus Sir2p appeared to be a
deacetylase that uses NAD as a cofactor!
In a second study, Imai et al. [21] used chromatographic
methods and mass spectroscopy to look for addition of an
ADP-ribose moiety onto synthetic histone peptides [21].
While there was no evidence for such a modification with
purified Sir2p and NAD, this group also discovered that
when histone H3 or H4 peptides with acetylated lysines
were used, the acetyl groups were removed during the incu-
bation. Several previously characterized histone deacetyl-
ases are inhibited by drugs such as trichostatin A [23].
Incubation of Sir2p with this compound, however, had no
effect on its deacetylase activity. This resistance to the drug
contributes to the notion that Sir2p and its homologues
represent a new class of deacetylase enzymes. These
researchers also noted a weak ADP-ribosyltransferase activ-
ity when histone H3 peptides were a substrate. The weak
activity could not, however, be detected by mass spec-
troscopy, only through the sensitivity of autoradiography.
In the third study, Smith et al. [22] confirmed that Sir2p
and its homologues are NAD-dependent deacetylases, but
they reported an additional interesting observation. In an
earlier mutant hunt for genes required for rDNA silencing
in yeast, a null allele of the NPT1 gene was identified.
This gene encodes a homologue of an enzyme involved in
an NAD salvage pathway in bacteria. Consistent with the
yeast protein Npt1p performing a similar function to its
bacterial relative, levels of NAD were found to be reduced
2.5-fold in an npt1– strain. This provides in vivo support for
the idea that Sir2p is an NAD-dependent enzyme. (This
is a wonderful lesson for geneticists that think some of
their non-obvious mutants are ‘garbage’.)
Sir2 as a deacetylase.
The discovery that Sir2p is a lysine deacetylase (Figure 1a),
which works on histones, provides a crucial missing piece in
understanding how silent chromatin may be created and
maintained. This activity offers a very plausible mechanism
for the hypoacetylation of histones. It also raises the level of
detail of the questions that can be asked. Does Sir2p
deacetylate histones that are newly deposited upon the
DNA during replication of silent chromatin domains? Such
a scenario would permit its Sir partners to bind and blanket
the nucleosomes. Is it required after DNA replication as
well, to maintain silent chromatin? Though we may
imagine structures such as silent chromatin as static, repres-
sive walls, they are probably quite dynamic. Perhaps Sir2p
is needed to maintain a proper foundation of hypoacety-
lated histones when Sir3 or Sir4p transiently leave the wall. 
As a word of caution, a more important question to be
answered is whether Sir2p’s relevant silencing substrates
are indeed histones. All the evidence says ‘yes’, but the
smallest doubt must linger. In vitro, members of the Sir2
family of proteins are capable of working on all types of
substrates — bovine serum albumin, for example —
without significant specificity [18]. Most likely the
proteins that Sir2 family members partner with determine
the relevant substrates. 
Sir2 and NAD
It is quite clear that the deacetylase activity of Sir2p
requires NAD, and that this provides an interesting link
between the metabolic energy flow of the cell and silenc-
ing. But the apparent activity of Sir2 and its homologues on
NAD is distinct from our typical textbook knowledge of
NAD. NAD is not used as a coenzyme by Sir2p to transfer
electrons and H+ ions, as it is in so many characterized
reactions of the tricarboxylic acid cycle and other redox
reactions. Instead, the evidence supports the idea that
Sir2p cleaves the bond between nicotinamide and ribose-
ADP (Figure 1b). The reason for this cleavage and the true
fate of these two moieties remain to be determined. 
While Sir2p and its homologues have ADP-ribosyltrans-
ferase activity in vitro, this activity seems to be quite weak
compared to the deacetylase activity. Similarly, while
Sir2p and its homologues, such as CobB, can also transfer
nicotinamide to small molecule substrates when expressed
in bacteria, it is unclear whether this is relevant to silenc-
ing. Perhaps energy gained by cleavage of the glycosidic
bond is used to lower the activation energy of the deacety-
lase reaction, similar to how NAD is used as a cofactor by
Escherichia coli DNA ligase [24]. Alternatively, NAD may
be an allosteric effector. 
Closing remarks
It is tempting to consider that Sir2p may serve as a node
for connecting the networks of cellular physiology and
genomic silencing. Perhaps when levels of NAD are
reduced as a result of decreased precursor pools — such as
those of tryptophan, glutamine and ATP — multiple
genomic domains are ‘opened’ to explore alternative ways
for bettering the cell’s environment. Nevertheless, what-
ever roles Sir2p may play, there is still plenty of ‘sport’ left
to understand chromatin domains of the genome.
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